Carlisle Companies Incorporated (CSL)

Operating return on assets (Operating ROA)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Operating income (ttm) US$ in thousands 982,800 938,700 962,800 1,057,800 1,214,400 1,187,400 1,029,900 760,100 567,500 496,300 484,600 465,300 483,300 513,300 549,500 642,200 654,200 627,500 576,500 529,000
Total assets US$ in thousands 6,620,000 6,816,000 7,176,200 7,115,400 7,222,000 7,732,000 7,577,700 7,323,000 7,246,800 7,074,600 5,839,300 5,752,200 5,866,400 5,800,000 5,808,300 6,297,600 5,496,000 5,541,100 5,396,700 5,301,700
Operating ROA 14.85% 13.77% 13.42% 14.87% 16.82% 15.36% 13.59% 10.38% 7.83% 7.02% 8.30% 8.09% 8.24% 8.85% 9.46% 10.20% 11.90% 11.32% 10.68% 9.98%

December 31, 2023 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $982,800K ÷ $6,620,000K
= 14.85%

The operating return on assets (operating ROA) of Carlisle Companies Inc. has been relatively stable over the past eight quarters, ranging from a low of 10.28% in Q1 2022 to a high of 17.93% in Q4 2022. The trend shows a slight decrease in operating ROA in recent quarters, with the latest quarter, Q4 2023, reporting a rate of 14.81%. This indicates that the company is generating approximately 14.81 cents in operating income for every dollar of assets it holds. Overall, while the operating ROA has fluctuated, Carlisle Companies Inc. has been able to maintain consistent profitability relative to its asset base.


Peer comparison

Dec 31, 2023

Company name
Symbol
Operating ROA
Carlisle Companies Incorporated
CSL
14.85%
West Pharmaceutical Services Inc
WST
17.65%